Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHL TelemedicineSHMLF 52 Debt-to-Equity is 0.30 as of Dec. 2025, which is 25% below its 10-year median of 0.40. GuruFocus rates SHMLF with a GF Score™ of 52/100 and a GF Value™ of $12.26. The stock has 3 warning signs investors should review. Among 558 Healthcare Providers & Services companies, SHL Telemedicine ranks better than 58.96% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for SHL Telemedicine's Debt-to-Equity or its related term are showing as below:
SHMLF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.4 Max: 0.99
Current: 0.3
During the past 13 years, the highest Debt-to-Equity Ratio of SHL Telemedicine was 0.99. The lowest was 0.03. And the median was 0.40.
SHMLF's Debt-to-Equity is ranked better than 58.96% of 558
companies
in the Healthcare Providers & Services industry
Industry Median: 0.405
vs SHMLF: 0.30
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
SHL Telemedicine Debt-to-Equity Related Terms
SHL Telemedicine Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for SHL Telemedicine's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHMLF vs VEEV, BTSG, TEM: Debt-to-Equity Comparison
For the Health Information Services subindustry, SHL Telemedicine's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SHL Telemedicine Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where SHL Telemedicine's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHL Telemedicine (SHMLF) has a Debt-to-Equity of 0.30 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on SHL Telemedicine and its competitors. This is 25% below median its historical median of 0.40. Over the past decade, SHL Telemedicine's Debt-to-Equity has ranged from 0.03 to 0.99. According to the industry distribution chart, SHL Telemedicine ranks #229 out of 558 companies in the Healthcare Providers & Services industry, placing it in the top 41%.
Is SHL Telemedicine's Debt-to-Equity too high?
SHL Telemedicine's current Debt-to-Equity of 0.30 is 25% below median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.99. The Healthcare Providers & Services industry median Debt-to-Equity is 0.41. SHL Telemedicine's value of 0.30 is 25.9% below this industry median. Based on the distribution chart, SHL Telemedicine ranks #229 out of 558 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, SHL Telemedicine has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Debt-to-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SHL Telemedicine ranks #229 out of 558 companies for Debt-to-Equity. This puts SHL Telemedicine in the upper half of its industry. The industry median Debt-to-Equity is 0.41. SHL Telemedicine's value of 0.30 is 25.9% below this benchmark. Historically, SHL Telemedicine's own Debt-to-Equity has ranged from 0.03 to 0.99 over the past decade. While the company's 10-year median is 0.40 vs. the industry median of 0.41, SHL Telemedicine has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 558 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SHL Telemedicine's current Debt-to-Equity of 0.30 is 25.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on SHL Telemedicine and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SHL Telemedicine's current Debt-to-Equity is 0.30, which is 25% below median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
SHL Telemedicine (SHMLF) has a current Debt-to-Equity of 0.30. The stock's GF Value™ is $12.26, compared to a current price of $4.84 — trading 60.5% below its estimated fair value. The current Debt-to-Equity is 0.30, which is 25% below median its 10-year median of 0.40 and 25.9% below the Healthcare Providers & Services industry median of 0.41. SHL Telemedicine's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For SHL Telemedicine (SHMLF), the current Debt-to-Equity is 0.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SHL Telemedicine (SHMLF) Overvalued in 2026?
Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued.
The current stock price of $4.84 is trading 60.5% below its estimated GF Value™ of $12.26.
Key valuation signals for SHMLF:
Debt-to-Equity: 0.30 (25% below median its 10-year median of 0.40)
GF Value™: $12.26 vs. price of $4.84 (60.5% below fair value)
Industry Position: 25.9% below the Healthcare Providers & Services median (#229 of 558)
No single metric tells the full story. See the SHMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
52GF Score
Get the complete analysis for SHMLF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHMLF has been successfully added to your 
